Diseases of the basal ganglia account for many neurologic and neuropsychiatric disorders, such as Parkinson's and Huntington's Diseases. Progress in understanding the functional organization and pathophysiology of the basal ganglia has been rapid. Much of this work has been integrated into a working model of basal ganglia circuitry that can account for both normal and abnormal behavior. The present proposal represents a multi-disciplinary effort, including neuroanatomical, electrophysiological, neuropharmacological, neurosurgical, and behavioral approaches to further our understanding of the structural and functional organization of the basal ganglia within the framework of this model. According to the model there exists a family of 'basal ganglia- thalamocortical circuits' that are organized in a parallel fashion, largely secreted one from another, both structurally and functionally. In the primate, """"""""motor"""""""" """"""""Oculomotor"""""""", """"""""associative and """"""""limbic"""""""" circuits have been described which take origin from specific cortical areas. Within each circuit, there appears to exist even further parallel features, e.g., the striatum, the major input structure of the basal ganglia, influences the internal pallidum, the major output structure, via parallel """"""""direct"""""""" and indirect"""""""" pathways. Project 1 address the role of recently discovered dopamine and muscarinic acetylcholine receptor gene families with the primate basal ganglia. Using subtype-specific antibodies to the receptors, the molecular pharmacology and anatomy of identified striatal circuits will be delineated. These studies will help identify the best targets for new drugs aimed at the subtypes for better treatment of movement disorders. Project 2 addressed the basis model at the level of brainstem interactions with the basal ganglia-thalamocortical circuitry. This project will help to elucidate the influence of the midbrain tegmentum on movement and basal ganglia-thalamocortical circuits at the level of the internal pallidum (GPi) on parkinsonian signs in monkeys with experimental parkinsonism. Correlation of behavioral changes with lesion sites as determined electrophysiologically and by MRI will help to optimize the outcome and reduce surgical complications. Data from this study will also help to elucidate the pathophysiology of these disorders and will lead to improved surgical treatment strategies. Project 4 explores the issue of segregated functions of the associative/oculomotor and motor circuits as regards the phenomenon of adaption to prism-induced and tendon-induced target displacements. This adaptation involves two additive components - a visual and a proprioceptive shift, both of which appear to depend on the integrity of separate basal ganglia circuits. Together these studies will extend out understanding of basal ganglia function, help to elucidate the pathophysiologic basis of basal ganglia disorders and lead to new innovative therapies for these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS031937-04
Application #
2416325
Study Section
Neurological Disorders Program Project Review B Committee (NSPB)
Program Officer
Oliver, Eugene J
Project Start
1994-05-01
Project End
1999-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Emory University
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Turner, R S; DeLong, M R (2000) Corticostriatal activity in primary motor cortex of the macaque. J Neurosci 20:7096-108
Ciliax, B J; Nash, N; Heilman, C et al. (2000) Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37:125-45
Miller, G W; Erickson, J D; Perez, J T et al. (1999) Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Exp Neurol 156:138-48
Ciliax, B J; Drash, G W; Staley, J K et al. (1999) Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409:38-56
Sesack, S R; Hawrylak, V A; Matus, C et al. (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697-708
Erickson, S L; Akil, M; Levey, A I et al. (1998) Postnatal development of tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. Cereb Cortex 8:415-27
Emborg, M E; Ma, S Y; Mufson, E J et al. (1998) Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol 401:253-65
Ince, E; Ciliax, B J; Levey, A I (1997) Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse 27:357-66
Betarbet, R; Turner, R; Chockkan, V et al. (1997) Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17:6761-8
Hersch, S M; Yi, H; Heilman, C J et al. (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-27

Showing the most recent 10 out of 18 publications